Recap: Himax Technologies Q2 Earnings

  Shares of Himax Technologies (NASDAQ:HIMX) rose 7.0% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 6100.00% year over year to $0.62, which beat the estimate of $0.46.

 

Shares of Himax Technologies (NASDAQ:HIMX) rose 7.0% in pre-market trading after the company reported Q2 results.

Quarterly Results

Earnings per share rose 6100.00% year over year to $0.62, which beat the estimate of $0.46.

Revenue of $365,261,000 rose by 95.34% from the same period last year, which beat the estimate of $324,700,000.

Guidance

Q3 EPS expected between $0.75 and $0.81.

Q3 revenue expected to be between $412,745,000 and $427,355,000.

Conference Call Details

Date: Aug 05, 2021

Time: 08:00 AM

ET Webcast URL: https://edge.media-server.com/mmc/p/hbt43kh5

Technicals

52-week high: $17.88

Company’s 52-week low was at $3.28

Price action over last quarter: Up 15.47%

Company Overview

Himax Technologies Inc is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The majority of the firm’s revenue gets derived from the Driver Integrated Circuit segment. It offers display driver ICs and timing controllers used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, virtual reality (VR) devices, and many other consumer electronics devices. It also designs and provides controllers for touch sensor displays, in-cell Touch and Display Driver Integration single-chip solutions, LED driver ICs, power management ICs, scaler products for monitors and projectors. Geographically, it generates the majority of its revenue from China.

Total
0
Shares
Related Posts
Read More

Bruker Corp Preliminary Expectation For Revenue For Q4 2022 To Be Up Low Single Digits % YoY, A Result Of Organic Growth Of Mid-To-High Single Digits % YoY; Initial Guidance For 2023 For Organic Revenue Growth Up Mid-To-High Single Digit % YoY

On January 9, 2023 during its scheduled presentation at the 41st Annual J.P. Morgan Healthcare Conference, Bruker Corporation (the “Company”) stated that its current preliminary expectation for revenue for

BRKR

Read More

Cleveland Beige Book: The pace of business activity quickened, and contacts expect that demand will remain strong in the near term. However, supply chain bottlenecks constrained growth and caused materials costs to escalate.

Cleveland The pace of business activity quickened, and contacts expect that demand will remain strong in the near term. However, supply chain bottlenecks constrained growth and caused materials costs to escalate. Price

SPY